Characterization of the human SLC2A11 (GLUT11) gene: Alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue

Molecular Membrane Biology

Volumn 22, Issue 4, 2005, Pages 339-351

  Scheepers, Andrea ^a   Schmidt, Stefan ^a   Manolescu, Andrei ^b   Cheeseman, Chris I ^b   Bell, Andreas ^c   Zahn, Claudia ^a   Joost, Hans Georg ^a   Schürmann, Annette ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Alternative promoter usage; Glucose transport activity; GLUT family; Orthologuous genes; Tissue specific isoforms

Indexed keywords

FRUCTOSE; GALACTOSE; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 11; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME SPECIFICITY; EXON; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; HEART; HUMAN; KIDNEY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PANCREAS; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPECIES COMPARISON; TISSUE SPECIFICITY; XENOPUS LAEVIS;

ALTERNATIVE SPLICING; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EXONS; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MICE; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; PROTEIN TRANSPORT; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUBCELLULAR FRACTIONS; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; XENOPUS LAEVIS;

ANIMALIA; XENOPUS LAEVIS;

EID: 27144551337     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.1080/09687860500166143     Document Type: Article

References (33)

1. Joost H-G, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: Nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 2001;18:247-256.
2. Wu X, Freeze HH. GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 2002;80:553-557.
3. Miyamoto K, Hase K, Takagi T, Fujii T, Taketani Y, Minami H, Oka T, Nakabou Y. Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars. Biochem J 1993;295:211-215.
4. Uldry M, Ibberson M, Horisberger JD, Chatton JY, Riederer BM, Thorens B. Identification of a mammalian H(+)-myoinositol symporter expressed predominantly in the brain. EMBO J 2001;20:4467-4477.
5. Scheepers A, Doege H, Joost H-G, Schürmann A. Mouse GLUT8: Genomic organization and regulation of expression in 3T3-L1 adipocytes by glucose. Biochem Biophys Res Commun 2001;288:969-974.
6. Doege H, Bocianski A, Scheepers A, Axer H, Eckel J, Joost H-G, Schürmann A. Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle. Biochem J 2001;359:443-449.
7. Gaster M, Handberg A, Schürmann A, Joost H-G, Beck-Nielsen H, Schoder HD. GLUT11 but not GLUT8 and GLUT12, is expressed in human skeletal muscle in a fiber type-specific pattern. Pflugers Arch 2004;448:105-113.
8. Sasaki T, Minoshima S, Shiohama A, Shintani A, Shimizu A, Asakawa S, Kawasaki K, Shimizu N. Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11 (SLC2A11) and identification of transcription variants. Biochem Biophys Res Commun 2001;289:1218-1224.
9. Wu X, Li W, Sharma V, Godzik A, Freeze HH. Cloning and characterization of glucose transporter 11, a novel sugar transporter that is alternatively spliced in various tissues. Mol Genet Metab 2002;76:37-45.
10. Chenchik A, Siebert P. Studying tissue-specific gene expression with Marathon-Ready cDNAs. CLONTECHniques 1996;XI:22.
11. Schurmann A, Monden I, Joost H-G, Keller K. Subcellular distribution and activity of glucose transporter isoforms GLUT1 and GLUT4 transiently expressed in COS-7 cells. Biochim Biophys Acta 1992;1131:245-252.
12. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-7654.
13. Kalnina Z, Zayakin P, Silina K, Line A. Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 2005;42:342-357.
14. Augustin A, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): Alternative splicing alters trafficking. J Biol Chem 2004;279:16229-16236.
15. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F. The formation of skeletal muscle: from somite to limb. J Anat 2003;202:59-68.
16. Naya FS, Olson E. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 1999;11:683-688.
17. Parmacek MS, Ip HS, Jung F, Shen T, Martin JF, Vora AJ, Olson EN, Leiden JM. A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle. Mol Cell Biol 1994;14:1870-1885.
18. Hidaka K, Yamamoto I, Arai Y, Mukai T. The MEF-3 motif is required for MEF-2-mediated skeletal muscle-specific induction of the rat aldolase A gene. Mol Cell Biol 1993;13:6469-6478.
19. Salminen M, Lopez S, Maire P, Kahn A, Daegelen D. Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice. Mol Cell Biol 1996;16:76-85.
20. Spitz F, Demignon J, Porteu A, Kahn A, Concordet JP, Daegelen D, Maire P. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc Natl Acad Sci USA 1998;95:14220-14225.
21. James DE, Strube M, Mueckler M. Molecular cloning and characterization of an insulin regulatable glucose transporter. Nature 1989;338:83-87.
22. Birnbaum MJ. Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 1989;57:305-315.
23. Liu ML, Olson AL, Edgington NP, Moye-Rowley WS, Pessin JE. Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. J Biol Chem 1994;269:28514-28521.
24. Thai MV, Guruswamy S, Cao KT, Pessin JE, Olson AL. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 1998;273:14285-14292.
25. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L, Mabry M, Ball DW, Baylin SB, Nelkin BD. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996;16:5335-5345.
26. Ginsberg D. E2F1 pathways to apoptosis. FEBS Lett 2002;529:122-125.
27. Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S, Lees JA. E2f3 is critical for normal cellular proliferation. Genes Dev 2000;14:690-703.
28. Murphy WJ, Eizirik E, O'Brien SJ, Madsen O, Scally M, Douady CJ, Teeling E, Ryder OA, Stanhope MJ, de Jong WW, Springer MS. Resolution of the early placental mammal radiation using baysian phylogenetics. Science 2001;294:2348-2351.
29. Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, Leonard JV, Moses S, Norgren S, Skovby F, Schneppenheim R, Steinmann B, Schaub J. The mutation spectrum of the facultative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet 2002;110:21-29.
30. Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome - a congenital defect of facultative glucose transport. Curr Mol Med 2002;2:213-227.
31. Thorens B, Guillam MT, Beermann F, Burcelin R, Jaquet M. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000;275:23751-23758.
32. Guillam MT, Dupraz P, Thorens B. Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes 2000;49:1485-1491.
33. Thorens B. GLUT2 in pancreatic and extra-pancreatic gluco-detection. Mol Membr Biol 2001;18:265-273.